Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader
with a comprehensive review of key pre-clinical research components required to identify …

The practice of radiation oncology is currently primarily based on precise technical delivery
of highly conformal, image-guided radiation treatments. The precision medicine revolution …

Use of radiation for cancer therapy began shortly after the discovery of X-rays in 1895.
Technological advances over the ensuing 120 years have enabled the development of …

Radiation therapy is a highly effective cancer treatment modality, and extensive
investigations have been undertaken over the years to augment its efficacy in the clinic. This …

It is estimated that in 2008 1.4 million patients in North America will be diagnosed with a
nonskin form of cancer (www. cancer. org), of which seventy-five percent will receive …

The development of molecular targeted drugs with radiation and chemotherapy is critically
important for improving the outcomes of patients with hard-to-treat, potentially curable …

Predictive biomarkers that allow rational selection of treatments for individual patients have
played a central role in precision oncology. While such biomarkers have transformed …

The first annual workshop for preclinical and clinical development of radiosensitizers took
place at the National Cancer Institute on August 8–9, 2012. Radiotherapy is one of the most …

Over the past several years, significant technological and biological progress has been
made in radiation oncology with focus on the development of new treatment schemes to …

Radiotherapy is a standard cytotoxic therapy against solid cancers. It uses ionizing radiation
to kill tumor cells through damage to DNA, either directly or indirectly. Radioresistance is …